Society of Gynecologic Oncology to Host 43rd Annual Meeting on Women’s Cancer®
CHICAGO, Feb. 2, 2012 /PRNewswire-USNewswire/ — The Society of Gynecologic Oncology (SGO) will host its 43rd Annual Meeting on Women’s Cancer® March 24-27, 2012, at the Austin Convention Center, Austin, TX.
The meeting’s featured keynote speaker is Harald zur Hausen, who was awarded the Nobel Prize in Medicine for his pioneering discovery of the role of human papilloma virus (HPV) in the development of cancer of the cervix. He currently is professor emeritus, after having served as Chairman of the Management Board and Scientific Director of the German Cancer Research Center, Heidelberg, Germany.
The Annual Meeting will feature more than 400 scientific presentations in addition to lectures, workshops, symposia, surgical and education forums and interactive debates that focus on emerging science, clinical trials and treatment in the field of gynecologic oncology. The programming covers surgical disease management, comprehensive multidisciplinary treatment, preventative medicine and scientific research.
Under the leadership of Scott McMeekin, M.D., Program Chair of the 43rd meeting, this year’s meeting offers new formats and innovative combinations of education sessions. New in 2012 will be an emphasis on attendee interaction and disease-specific programming, as well as technology like webcasting and social media to enhance the meeting experience.
“As the Society’s premier educational event, the meeting provides an important forum for the exchange of ideas that impact future research and positively affect the subspecialty of gynecologic oncology,” says SGO President John P. Curtin, M.D. “The Annual Meeting truly advances SGO’s goal of improving cancer prevention and the level of care for women around the world.”
About the SGO
The Society of Gynecologic Oncology (SGO) is a national medical specialty organization of physicians and allied healthcare professionals who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge that will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women’s health care, oncology and related fields. The Society’s membership, totaling more than 1,400, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists, nurses, social workers and pathologists. SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care. More information on the SGO can be found at www.sgo.org.
SOURCE Society of Gynecologic Oncology